EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy

Ievgen Koliesnik, Michael Totagrande, Bhargavi Jayaraman, Ryan Burgess, Kim Quyen Tran, Michele Bauer, Priyanka Balasubrahmanyam, Mohammed Ali, Henry Rosas, Jan Emmerich, Deepti Chaturvedi, Deepti Rokkam und 14 weitere

Cell Reports · 2026-01 · 45 (1) · 116757

DOI: 10.1016/j.celrep.2025.116757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-01. Verfasst von Ievgen Koliesnik und 25 weiteren Autor:innen. Beteiligte Einrichtung: Synthekine Inc., Menlo Park, CA, USA. Hauptthemen laut MEDLINE: Interleukin-12, Lymphocyte Activation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-12Lymphocyte ActivationAnimalsMiceKiller Cells, NaturalLymphocytes, Tumor-InfiltratingMice, Inbred C57BLHumansImmunotherapyFemaleCell Line, TumorReceptors, Interleukin-12Interferon-gamma

Stichwörter der Autor:innen

CP: ImmunologyIL-12IL-12Rβ1IL-12Rβ2NK cellsSTK-026cytokineimmunotherapyinterleukin 12t cells

Substanzen

Interleukin-12Receptors, Interleukin-12Interferon-gamma

Autor:innen und Institutionen

  • Synthekine Inc., Menlo Park, CA, USA.
  • Synthekine Inc., Menlo Park, CA, USA. Electronic address: moft@synthekine.com.
  • Synthekine Inc., Menlo Park, CA, USA. Electronic address: plupardus@synthekine.com.

Zitieren

APA

Koliesnik, I., Totagrande, M., Jayaraman, B., Burgess, R., Tran, K. Q., Bauer, M., Balasubrahmanyam, P., Ali, M., Rosas, H., Emmerich, J., Chaturvedi, D., Rokkam, D., Singh, S., Chang, W., Buffone, C., Mehta-Damani, A., de Waal Malefyt, R., Greb, H., Ratti, N., …, & Lupardus, P. J. (2026). An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy. Cell Reports, 45(1), 116757. https://doi.org/10.1016/j.celrep.2025.116757

Vancouver

Koliesnik I, Totagrande M, Jayaraman B, Burgess R, Tran KQ, Bauer M, et al. An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy. Cell Reports. 2026;45(1):116757. doi:10.1016/j.celrep.2025.116757

BibTeX
@article{Koliesnik2026,
  author = {Koliesnik, Ievgen and Totagrande, Michael and Jayaraman, Bhargavi and Burgess, Ryan and Tran, Kim Quyen and Bauer, Michele and Balasubrahmanyam, Priyanka and Ali, Mohammed and Rosas, Henry and Emmerich, Jan and Chaturvedi, Deepti and Rokkam, Deepti and Singh, Somya and Chang, Woei and Buffone, Cindy and Mehta-Damani, Anita and de Waal Malefyt, Rene and Greb, Heiko and Ratti, Navneet and Rosen, David B and Zuniga, Luis and Kastelein, Robert A and Aspuria, Paul-Joseph and Vivona, Sandro and Oft, Martin and Lupardus, Patrick J},
  title = {An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {1},
  pages = {116757},
  doi = {10.1016/j.celrep.2025.116757}
}
Kostenlos starten →